The Solana Foundation's validator delegation program supports eligible validators to improve network decentralization and performance, with a 12-month membership term starting at mainnet eligibility. However, the program's exit rules conflict on outside stake thresholds, citing both 300,000 SOL and 1 million SOL without clarifying which applies. There is no stated cap on total membership, despite references to 100-validator onboarding batches. As of Epoch 1079, 327 validators receive Foundation stake totaling 23.75 million SOL, about 5% of total staked SOL. Support tapers over the year to encourage sustainable stake levels before ending.
The Solana Foundation Validator Program involves 327 validators receiving a total of 23.75 million SOL stake as of Epoch 1079, representing about 5% of total staked SOL. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 09, 2026 01:02 WIB: out of 50 priced major cryptocurrencies, 8 rose and 40 fell today. Notable movers include EGLD (MultiversX) with a price of Rp53.931 and a 1-day change of -5.11%, FIL (Filecoin) at Rp13.839 with -4.75%, and XTZ (Tezos) at Rp4.567 with -4.32%.
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...
Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...
Bitcoin Cash (BCH) fell about 4.5% on November 8, extending its weekly losses beyond 13%, while Bitcoin remained stable near $75,800. BCH's price dropped below key support levels around $250 and tested $244, signaling weaker demand compared to Bitcoi...
